Treatment with 5-fluoro-2-oxindole Increases the Antinociceptive Effects of Morphine and Inhibits Neuropathic Pain

doi:10.1007/s10571-020-00952-w

Paper

Treatment with 5-fluoro-2-oxindole Increases the Antinociceptive Effects of Morphine and Inhibits Neuropathic Pain

Published Sep 2, 2020 · Pablo Ferreira-Chamorro, A. Redondo, Gabriela Riego

Cellular and Molecular Neurobiology

Q1 SJR score

10

Citations

0

Influential Citations

Full textSemantic Scholar

Abstract

The efficacy of µ-opioid receptors (MOR) in neuropathic pain is low and with numerous side effects that limited their use. Chronic neuropathic pain is also linked with emotional disorders that aggravate the sensation of pain and which treatment has not been resolved. This study investigates whether the administration of an oxindole, 5-fluoro-2-oxindole, could inhibit the nociceptive and emotional behaviors and increase the effectiveness of morphine via modulating the microglia and activating the nuclear factor erythroid-2 related factor 2 (Nrf2) signaling pathway and MOR expression. In C57BL/6 mice with neuropathic pain provoked by the total constriction of sciatic nerve we studied the effects of 10 mg/kg 5-fluoro-2-oxindole in: (i) the allodynia and hyperalgesia caused by the injury; (ii) the anxiety- and depressive-like behaviors; (iii) the local antinociceptive actions of morphine; (iv) the expression of CD11b/c (a microglial marker), the antioxidant and detoxificant enzymes Nrf2, heme oxygenase 1 (HO-1) and NAD(P)H:quinone oxidoreductase-1 (NQO1), and of MOR in the spinal cord and hippocampus. Results showed that the inhibition of the main nociceptive symptoms and the anxiety- and depressive-like behaviors induced by 5-fluoro-2-oxindole were accompanied with the suppression of microglial activation and the activation of Nrf2/HO-1/NQO1 signaling pathway in the spinal cord and/or hippocampus. This treatment also potentiated the pain-relieving activities of morphine by normalizing the reduced MOR expression. This work demonstrates the antinociceptive, anxiolytic and antidepressant effects of 5-fluoro-2-oxindole, suggests a new strategy to enhance the antinociceptive actions of morphine and proposes a new mechanism of action of oxindoles during chronic neuropathic pain.

Non-RCT

Animal Study

Rigorous Journal

Study Snapshot

5-fluoro-2-oxindole effectively reduces neuropathic pain and anxiety-like behaviors by inhibiting microglial activation and activating -opioid receptors.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Sign up to use Study Snapshot

Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.

Create an account

Paper

Treatment with 5-fluoro-2-oxindole Increases the Antinociceptive Effects of Morphine and Inhibits Neuropathic Pain

Sign up to use Study Snapshot

References

Treatment with slow-releasing hydrogen sulfide donors inhibits the nociceptive and depressive-like behaviours accompanying chronic neuropathic pain: Endogenous antioxidant system activation

Slow-releasing hydrogen sulfide donors, allyl isothiocyanate and phenyl isothiocyanate, may be a promising treatment for chronic neuropathic pain and associated comorbidities by inhibiting inflammation and activating endogenous antioxidant responses.

The Inhibitory Effects of Slow-Releasing Hydrogen Sulfide Donors in the Mechanical Allodynia, Grip Strength Deficits, and Depressive-Like Behaviors Associated with Chronic Osteoarthritis Pain

Slow-releasing hydrogen sulfide donors, allyl isothiocyanate and phenyl isothiocyanate, may help treat chronic osteoarthritis pain and emotional disorders by inhibiting mechanical allodynia, grip strength deficits, and depressive-like behaviors.

Isorhynchophylline exerts anti-asthma effects in mice by inhibiting the proliferation of airway smooth muscle cells: The involvement of miR-200a-mediated FOXC1/NF-κB pathway.

Isorhynchophylline reduces asthma symptoms by inhibiting airway smooth muscle cell proliferation and promoting apoptosis, with its effect relying on the up-regulation of miR-200a and deactivation of the FOXC1/NF-B pathway.

Isorhynchophylline enhances Nrf2 and inhibits MAPK pathway in cardiac hypertrophy

Isorhynchophylline (IRN) shows potential in treating cardiac hypertrophy by enhancing Nrf2 and inhibiting MAPK pathway, improving cardiac function and preventing fibrosis.

Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic mouse model of Alzheimer’s disease

Isorhynchophylline (IRN) improves cognitive impairment in Alzheimer's disease mice by reducing amyloid generation, tau hyperphosphorylation, and neuroinflammation, with potential for further development as a pharmacological treatment for Alzheimer's disease.

Citations

Analgesic Effects of Fisetin, Peimine, Astaxanthin, Artemisinin, Bardoxolone Methyl and 740 Y-P and Their Influence on Opioid Analgesia in a Mouse Model of Neuropathic Pain

Fisetin, peimine, astaxanthin, bardoxolone methyl, and 740 Y-P effectively reduce tactile and thermal hypersensitivity in mice with peripheral neuropathy, with their combined use enhancing opioid analgesia.

Antiferroptotic Activities of Oxindole GIF-0726-r Derivatives: Involvement of Ferrous Iron Coordination and Free-Radical Scavenging Capacities.

Oxindole GIF-0726-r derivatives with a 4-(dimethylamino)benzyl moiety at C-3 and some types of bulky group at C-5 can suppress ferroptosis, warranting safety and efficacy evaluations in animal models of disease.

The Effects of Nuclear Factor Erythroid 2 (NFE2)-Related Factor 2 (Nrf2) Activation in Preclinical Models of Peripheral Neuropathic Pain

Nrf2 activation in preclinical models can alleviate peripheral neuropathic pain by reducing oxidative stress, neuroinflammation, and mitochondrial dysfunction.

The Beneficial Effects of Heme Oxygenase 1 and Hydrogen Sulfide Activation in the Management of Neuropathic Pain, Anxiety- and Depressive-like Effects of Paclitaxel in Mice

CoPP and GYY4137 show potential in treating neuropathic pain, anxiety- and depressive-like effects of paclitaxel in mice, mainly through antioxidant responses and inhibiting oxidative stress.

The Anxiolytic and Antidepressant Effects of Diallyl Disulfide and GYY4137 in Animals with Chronic Neuropathic Pain

DADS and GYY4137 show anxiolytic, antidepressant, and analgesic properties in chronic neuropathic pain, supporting their potential use in managing affective disorders associated with this condition.

Ultrasound-Engineered fabrication of immobilized molybdenum complex on Cross-Linked poly (Ionic Liquid) as a new acidic catalyst for the regioselective synthesis of pharmaceutical polysubstituted spiro compounds

Ultrasound irradiation effectively fabricates a novel catalyst for the regioselective synthesis of pharmaceutical polysubstituted spiro compounds, improving particle uniformity, specific surface area, and catalytic efficiency.

Understanding Opioid Actions, Pain and Analgesia: A Tribute to Dr. Gavril Pasternak

This special issue highlights the contributions of Dr. Gavril W. Pasternak, a mentor and leading expert in opioid actions, pain, and analgesia, to understanding and treating opioid tolerance, withdrawal, and addiction.

The Antinociceptive, Antioxidant and Anti-Inflammatory Effects of 5-Fluoro-2-Oxindole during Inflammatory Pain

5-fluoro-2-oxindole effectively reduces chronic inflammatory pain by inhibiting plasticity, oxidative responses, and enhancing the antinociceptive effects of morphine.